Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study.
Identifieur interne : 000961 ( PubMed/Curation ); précédent : 000960; suivant : 000962Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study.
Auteurs : Matthew A. Brown [Australie] ; Paul A. Bird [Australie] ; Philip C. Robinson [Australie] ; Philip J. Mease [États-Unis] ; Filip Van Den Bosch [Belgique] ; Christine Surian [Australie] ; Heather Jones [États-Unis] ; Annette Szumski [États-Unis] ; Lisa Marshall [États-Unis] ; Zirke Wiid [Australie] ; Maxime Dougados [France]Source :
- Annals of the rheumatic diseases [ 1468-2060 ] ; 2017.
DOI: 10.1136/annrheumdis-2017-211313
PubMed: 28673924
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000964
Links to Exploration step
pubmed:28673924Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study.</title><author><name sortKey="Brown, Matthew A" sort="Brown, Matthew A" uniqKey="Brown M" first="Matthew A" last="Brown">Matthew A. Brown</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Brisbane</wicri:regionArea></affiliation></author><author><name sortKey="Bird, Paul A" sort="Bird, Paul A" uniqKey="Bird P" first="Paul A" last="Bird">Paul A. Bird</name><affiliation wicri:level="1"><nlm:affiliation>St George & Sutherland Clinical School, University of New South Wales, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>St George & Sutherland Clinical School, University of New South Wales, Sydney</wicri:regionArea></affiliation></author><author><name sortKey="Robinson, Philip C" sort="Robinson, Philip C" uniqKey="Robinson P" first="Philip C" last="Robinson">Philip C. Robinson</name><affiliation wicri:level="1"><nlm:affiliation>School of Medicine, University of Queensland and Royal Brisbane and Women’s Hospital, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>School of Medicine, University of Queensland and Royal Brisbane and Women’s Hospital, Brisbane</wicri:regionArea></affiliation></author><author><name sortKey="Mease, Philip J" sort="Mease, Philip J" uniqKey="Mease P" first="Philip J" last="Mease">Philip J. Mease</name><affiliation wicri:level="1"><nlm:affiliation>School of Medicine, Swedish Medical Center and University of Washington, Seattle, Washington, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>School of Medicine, Swedish Medical Center and University of Washington, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Bosch, Filip Van Den" sort="Bosch, Filip Van Den" uniqKey="Bosch F" first="Filip Van Den" last="Bosch">Filip Van Den Bosch</name><affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Rheumatology, Ghent University Hospital, Ghent</wicri:regionArea></affiliation></author><author><name sortKey="Surian, Christine" sort="Surian, Christine" uniqKey="Surian C" first="Christine" last="Surian">Christine Surian</name><affiliation wicri:level="1"><nlm:affiliation>Speciality Care, Pfizer, West Ryde, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Speciality Care, Pfizer, West Ryde, New South Wales</wicri:regionArea></affiliation></author><author><name sortKey="Jones, Heather" sort="Jones, Heather" uniqKey="Jones H" first="Heather" last="Jones">Heather Jones</name><affiliation wicri:level="1"><nlm:affiliation>Inflammation & Immunology, Pfizer, Collegeville, Pennsylvania, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Inflammation & Immunology, Pfizer, Collegeville, Pennsylvania</wicri:regionArea></affiliation></author><author><name sortKey="Szumski, Annette" sort="Szumski, Annette" uniqKey="Szumski A" first="Annette" last="Szumski">Annette Szumski</name><affiliation wicri:level="1"><nlm:affiliation>Department of Biostatistics, inVentiv Health, Princeton, New Jersey, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Biostatistics, inVentiv Health, Princeton, New Jersey</wicri:regionArea></affiliation></author><author><name sortKey="Marshall, Lisa" sort="Marshall, Lisa" uniqKey="Marshall L" first="Lisa" last="Marshall">Lisa Marshall</name><affiliation wicri:level="1"><nlm:affiliation>Inflammation & Immunology, Pfizer, Collegeville, Pennsylvania, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Inflammation & Immunology, Pfizer, Collegeville, Pennsylvania</wicri:regionArea></affiliation></author><author><name sortKey="Wiid, Zirke" sort="Wiid, Zirke" uniqKey="Wiid Z" first="Zirke" last="Wiid">Zirke Wiid</name><affiliation wicri:level="1"><nlm:affiliation>Speciality Care, Pfizer, West Ryde, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Speciality Care, Pfizer, West Ryde, New South Wales</wicri:regionArea></affiliation></author><author><name sortKey="Dougados, Maxime" sort="Dougados, Maxime" uniqKey="Dougados M" first="Maxime" last="Dougados">Maxime Dougados</name><affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, University Pierre et Marie Curie Paris 6 Hôpital Cochin, AP-HP, INSERM U1153 and PRES Sorbonne Paris City, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Rheumatology, University Pierre et Marie Curie Paris 6 Hôpital Cochin, AP-HP, INSERM U1153 and PRES Sorbonne Paris City, Paris</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2017">2017</date><idno type="RBID">pubmed:28673924</idno><idno type="pmid">28673924</idno><idno type="doi">10.1136/annrheumdis-2017-211313</idno><idno type="wicri:Area/PubMed/Corpus">000964</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000964</idno><idno type="wicri:Area/PubMed/Curation">000961</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000961</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study.</title><author><name sortKey="Brown, Matthew A" sort="Brown, Matthew A" uniqKey="Brown M" first="Matthew A" last="Brown">Matthew A. Brown</name><affiliation wicri:level="1"><nlm:affiliation>Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Brisbane</wicri:regionArea></affiliation></author><author><name sortKey="Bird, Paul A" sort="Bird, Paul A" uniqKey="Bird P" first="Paul A" last="Bird">Paul A. Bird</name><affiliation wicri:level="1"><nlm:affiliation>St George & Sutherland Clinical School, University of New South Wales, Sydney, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>St George & Sutherland Clinical School, University of New South Wales, Sydney</wicri:regionArea></affiliation></author><author><name sortKey="Robinson, Philip C" sort="Robinson, Philip C" uniqKey="Robinson P" first="Philip C" last="Robinson">Philip C. Robinson</name><affiliation wicri:level="1"><nlm:affiliation>School of Medicine, University of Queensland and Royal Brisbane and Women’s Hospital, Brisbane, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>School of Medicine, University of Queensland and Royal Brisbane and Women’s Hospital, Brisbane</wicri:regionArea></affiliation></author><author><name sortKey="Mease, Philip J" sort="Mease, Philip J" uniqKey="Mease P" first="Philip J" last="Mease">Philip J. Mease</name><affiliation wicri:level="1"><nlm:affiliation>School of Medicine, Swedish Medical Center and University of Washington, Seattle, Washington, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>School of Medicine, Swedish Medical Center and University of Washington, Seattle, Washington</wicri:regionArea></affiliation></author><author><name sortKey="Bosch, Filip Van Den" sort="Bosch, Filip Van Den" uniqKey="Bosch F" first="Filip Van Den" last="Bosch">Filip Van Den Bosch</name><affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.</nlm:affiliation><country xml:lang="fr">Belgique</country><wicri:regionArea>Department of Rheumatology, Ghent University Hospital, Ghent</wicri:regionArea></affiliation></author><author><name sortKey="Surian, Christine" sort="Surian, Christine" uniqKey="Surian C" first="Christine" last="Surian">Christine Surian</name><affiliation wicri:level="1"><nlm:affiliation>Speciality Care, Pfizer, West Ryde, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Speciality Care, Pfizer, West Ryde, New South Wales</wicri:regionArea></affiliation></author><author><name sortKey="Jones, Heather" sort="Jones, Heather" uniqKey="Jones H" first="Heather" last="Jones">Heather Jones</name><affiliation wicri:level="1"><nlm:affiliation>Inflammation & Immunology, Pfizer, Collegeville, Pennsylvania, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Inflammation & Immunology, Pfizer, Collegeville, Pennsylvania</wicri:regionArea></affiliation></author><author><name sortKey="Szumski, Annette" sort="Szumski, Annette" uniqKey="Szumski A" first="Annette" last="Szumski">Annette Szumski</name><affiliation wicri:level="1"><nlm:affiliation>Department of Biostatistics, inVentiv Health, Princeton, New Jersey, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Biostatistics, inVentiv Health, Princeton, New Jersey</wicri:regionArea></affiliation></author><author><name sortKey="Marshall, Lisa" sort="Marshall, Lisa" uniqKey="Marshall L" first="Lisa" last="Marshall">Lisa Marshall</name><affiliation wicri:level="1"><nlm:affiliation>Inflammation & Immunology, Pfizer, Collegeville, Pennsylvania, USA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Inflammation & Immunology, Pfizer, Collegeville, Pennsylvania</wicri:regionArea></affiliation></author><author><name sortKey="Wiid, Zirke" sort="Wiid, Zirke" uniqKey="Wiid Z" first="Zirke" last="Wiid">Zirke Wiid</name><affiliation wicri:level="1"><nlm:affiliation>Speciality Care, Pfizer, West Ryde, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>Speciality Care, Pfizer, West Ryde, New South Wales</wicri:regionArea></affiliation></author><author><name sortKey="Dougados, Maxime" sort="Dougados, Maxime" uniqKey="Dougados M" first="Maxime" last="Dougados">Maxime Dougados</name><affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, University Pierre et Marie Curie Paris 6 Hôpital Cochin, AP-HP, INSERM U1153 and PRES Sorbonne Paris City, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Department of Rheumatology, University Pierre et Marie Curie Paris 6 Hôpital Cochin, AP-HP, INSERM U1153 and PRES Sorbonne Paris City, Paris</wicri:regionArea></affiliation></author></analytic><series><title level="j">Annals of the rheumatic diseases</title><idno type="eISSN">1468-2060</idno><imprint><date when="2017" type="published">2017</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">28673924</PMID><DateCreated><Year>2017</Year><Month>07</Month><Day>04</Day></DateCreated><DateRevised><Year>2017</Year><Month>07</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-2060</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2017</Year><Month>Jul</Month><Day>03</Day></PubDate></JournalIssue><Title>Annals of the rheumatic diseases</Title><ISOAbbreviation>Ann. Rheum. Dis.</ISOAbbreviation></Journal><ArticleTitle>Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">annrheumdis-2017-211313</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/annrheumdis-2017-211313</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Matthew A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Institute of Health and Biomedical Innovation, Queensland University of Technology, Translational Research Institute, Princess Alexandra Hospital, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bird</LastName><ForeName>Paul A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>St George & Sutherland Clinical School, University of New South Wales, Sydney, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Robinson</LastName><ForeName>Philip C</ForeName><Initials>PC</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Queensland and Royal Brisbane and Women’s Hospital, Brisbane, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mease</LastName><ForeName>Philip J</ForeName><Initials>PJ</Initials><AffiliationInfo><Affiliation>School of Medicine, Swedish Medical Center and University of Washington, Seattle, Washington, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bosch</LastName><ForeName>Filip van den</ForeName><Initials>FVD</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Ghent University Hospital, Ghent, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Surian</LastName><ForeName>Christine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Speciality Care, Pfizer, West Ryde, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Heather</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Inflammation & Immunology, Pfizer, Collegeville, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Szumski</LastName><ForeName>Annette</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Biostatistics, inVentiv Health, Princeton, New Jersey, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marshall</LastName><ForeName>Lisa</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Inflammation & Immunology, Pfizer, Collegeville, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiid</LastName><ForeName>Zirke</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Speciality Care, Pfizer, West Ryde, New South Wales, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dougados</LastName><ForeName>Maxime</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, University Pierre et Marie Curie Paris 6 Hôpital Cochin, AP-HP, INSERM U1153 and PRES Sorbonne Paris City, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016422">Letter</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Ann Rheum Dis</MedlineTA><NlmUniqueID>0372355</NlmUniqueID><ISSNLinking>0003-4967</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anti-TNF</Keyword><Keyword MajorTopicYN="N">magnetic resonance imaging</Keyword><Keyword MajorTopicYN="N">spondyloarthritis</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList><CoiStatement>Competing interests: MAB has received research grants, consulting fees or other remuneration or participated in speakers’ bureau for AbbVie, Novartis, Pfizer, UCB, Wyeth, Leo Pharma, NIAMS, NHMRC, Arthritis Australia and the Queensland Government; PAB has participated in speakers’ bureau for Pfizer, AbbVie, Roche, Janssen and BMS; PCR has received research grants, consulting fees or other remuneration from AbbVie, UCB, Janssen and Roche; PJM has received research grants, consulting fees or other remuneration or participated in speakers’ bureau for AbbVie, Amgen, BMS, Celgene, Crescendo, Genentech, Janssen, Lilly, Merck, Novartis, Pfizer and UCB; FvdB has received consulting fees or other remuneration, or participated in speakers’ bureau for AbbVie, Celgene, Janssen, Lilly, Merck, Novartis, Pfizer and UCB; CS and ZW are full-time employees of Pfizer Australia and hold stock or stock options; HJ and LM are full-time employees of Pfizer and hold stock or stock options; AS is an employee of InVentiv Health and was contracted by Pfizer to provide statistical support for the development of this manuscript; MD has received research grants, consulting fees or other remuneration from Pfizer, AbbVie, UCB, Merck, Novartis, Lilly and Sanofi.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>02</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2017</Year><Month>05</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>06</Month><Day>03</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2017</Year><Month>7</Month><Day>5</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28673924</ArticleId><ArticleId IdType="pii">annrheumdis-2017-211313</ArticleId><ArticleId IdType="doi">10.1136/annrheumdis-2017-211313</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000961 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000961 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:28673924
|texte= Evaluation of the effect of baseline MRI sacroiliitis and C reactive protein status on etanercept treatment response in non-radiographic axial spondyloarthritis: a post hoc analysis of the EMBARK study.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:28673924" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |